INTRODUCTION
============

Parkinson's disease (PD) is a neurodegenerative disease where midbrain dopamine neurons inexorably die. Cardinal manifestations of PD include bradykinesia, rigidity, resting tremor, and postural instability. PD patients also have non-motor manifestations such as constipation, salivation, sleep disorders, mood disorders, and cognitive deficits ([@B19]; [@B148]). Of these, executive dysfunction, one major domain of cognitive deficits in PD ([@B56]; [@B27]; [@B3]), is associated with considerable morbidity ([@B145]) and predicts future mortality ([@B123]; [@B49]).

Executive dysfunction affects roughly 30% of PD patients ([@B144]; [@B4]). Deficits in executive tasks may define a disease trajectory, as cognitive symptoms are prognosticators of dementia onset ([@B89]; [@B84],[@B85]; [@B66]). Such deficits can occur early in the disease ([@B48]; [@B2]) and involve impaired coordination of a range of cognitive processes required to achieve complex, goal-oriented, and novel cognitive operations ([@B39]; [@B73]). Executive processes include working memory, planning, inhibition, attention, and decreased speed of processing ([@B138]). These processes typically involve the frontal lobe ([@B52]). These impairments are revealed using classic tests of executive function ([@B132]) including verbal fluency, abstract reasoning, picture completion, Stroop performance ([@B1]), and performance on the Tower-of-London task ([@B48]). Executive functions can include inhibitory control ([@B134]; [@B117]) which may be impaired in PD ([@B146]; [@B102]). Other executive processes such as action selection can be impaired in PD and correlate with dysfunctional frontostriatal networks ([@B62]). Here, we are particularly interested in working memory aspects of executive function, as these appear to be involved in timing ([@B54]) and impaired in PD patients ([@B91]).

Importantly, PD-related executive dysfunction is not directly correlated with motor dysfunction ([@B132]), although it has been linked with gait-disturbance ([@B147]). Dopaminergic therapy does not reliably improve executive dysfunction in high-functioning ([@B113]) or moderate PD patients ([@B104]) and potentially can have detrimental effects ([@B24]; [@B25]).

In addition to deficits in executive dysfunction, patients with PD consistently have impaired timing (e.g., [@B9]; [@B110]; [@B91], [@B90]; [@B100]; [@B65]; [@B72]). While some consider timing an executive function ([@B52]), it is not universally considered as such ([@B39]; [@B73]). Executive functions classically involve goal-directed behavior such as planning, flexibility, problem solving, and attentional control ([@B10]; [@B109]; [@B86]) rather than timing. In this review, we discuss evidence that (1) timing tasks involve executive processing in the frontal cortex, and (2) frontal dysfunction may contribute to timing deficits in PD patients.

PERCEPTUAL TIMING
=================

Timing, i.e., the perception and estimation of time from seconds to minutes, is central in guiding a range of behaviors, from foraging and decision making to goal-directed behavior ([@B21]). Perceptual timing at this scale can be measured using a variety of interval timing tasks. These tasks require subjects to make responses at precise times indicating their internal and subjective estimates of time. Interval timing is conserved across a wide range of species ([@B15]), and is distinct from other measures such as motor timing, implicit timing, ordinal timing, and rhythmic timing.

In order to understand perceptual timing, it is useful to construct a detailed model which accounts both for timing behavior and errors in timing. Understanding the neural basis of timing models can be used to illuminate the mechanism of brain diseases which produce timing errors. One prominent model of timing is the scalar timing theory or scalar expectancy theory, also referred to as the pacemaker--accumulator model of timing ([@B54]). This model assumes the existence of a pacemaker that emits pulses at a certain rate, an accumulator that stores these pulses, and a decision module that constantly compares the accumulated pulses with an example sampled from memory. According to this model (**Figure [1](#F1){ref-type="fig"}**), a discriminative signal triggers the accumulation of the pulses, which are regularly compared with a randomly sampled number of pulses from the reference memory related to that discriminative signal. When the comparison crosses a threshold, a response is triggered ([@B22], [@B20]). Each component in this model produces variability, and at least of one these must be scalar, producing linearly increasing variance ([@B54]). Of note, there are alternative interval timing theories that, arguing for a lack of biological validity, do not assume the existence of a pacemaker/accumulator-type internal clock ([@B17]; [@B81]); but see [@B131] for a clock-like proposal of a neural model to estimate the passage of time). For instance, in a striatal beat--frequency model, striatal medium-spiny neurons serve as timers by detecting and integrating oscillatory states overtime ([@B93]; [@B97]; [@B6]). Of these, the scalar timing theory remains the most influential.

![**Scalar timing theory of interval timing based on that proposed by [@B21].** In this model, an external signal such as a sensory cue starts an internal clock, which compares the passage of time with a criterion stored in working memory. When the criterion approaches the actual clock time, a timed response is initiated. Extensive evidence has suggested that the striatum is involved in all aspects of interval timing ([@B99]). Both dorsal and ventral striatum receive dopaminergic input from the substantia nigra via the nigrostriatal pathway, and this pathway can influence timing ([@B95]). However, areas in the medial frontal cortex may also be involved ([@B29]), and likely influence memory as well as decision processes ([@B98]). These areas receive dopaminergic input (in red) from mesocortical dopamine projections originating from the ventral tegmental area. These mesocortical dopamine projections may contribute to perceptual timing deficits in PD patients.](fnint-07-00075-g001){#F1}

A link between interval timing and executive function is that classic tasks loading executive function impair interval timing ([@B13]). For instance, remembering items interfered with subjects' ability to reproduce temporal epochs ([@B50]). When children were asked to both estimate time and perform other executive processes, they were impaired ([@B121]). These type impairments in dual-task experiments suggest that increased dual-task allocation to executive processing resulted in a tradeoff with perceptual timing performance ([@B14]). Interference seemed to be specifically constrained to the executive process of updating working memory buffers ([@B111]). Taken together, these studies provide evidence that interval timing requires executive resources.

Perceptual timing has been reliably linked with dopamine signaling in the striatum ([@B15]; [@B71]). Interval timing can activate medial frontal regions ([@B59]; [@B65]), including supplementary and pre-supplementary areas ([@B103]; [@B29], [@B30]; [@B126]). Single neurons in medial prefrontal cortex are modulated by time ([@B108]; [@B97]; [@B53]; [@B107]). Rodent studies using pharmacological and optogenetic methods have found that prefrontal D1 dopamine signaling is required for interval timing ([@B105]). A recent temporal discrimination task described that neuronal ensembles in rodent medial frontal cortex were modulated by the passage of time ([@B76]). These results suggest that interval timing and executive functions share similar neural networks.

Previous reviews have discussed the neuroanatomy of timing in great detail ([@B93]; [@B15]; [@B95]; [@B28]; [@B29]). A central structure in interval timing is the striatum ([@B58]; [@B71]), likely favoring dorsal striatum ([@B80]). However, timing can involve diverse and distributed brain networks ([@B97]; [@B29]). In **Figure [1](#F1){ref-type="fig"}**, we have illustrated potential brain networks that underlie timing-related processes suggested by the scalar timing theory. For instance, it is clear that the striatum influences all aspects of perceptual timing, from clock functions to decision and memory mechanisms ([@B63], [@B64]; [@B30]; [@B99]). While temporal memory is certainly likely to involve frontal networks ([@B130]), recent reviews noted that medial frontal and medial premotor networks were consistently activated by perceptual timing tasks ([@B28]; [@B29]). These areas might provide "context" ([@B99]) and serve as executive control processes. Many of the frontal areas consistently activated include motor, supplementary motor, and cingulate cortex, which we posit are involved in the response decisions. Systematic recording and disruption experiments from this network in animal models will clarify the role of frontal cortex in memory vs. decision functions during interval timing.

DOPAMINE AND INTERVAL TIMING
============================

The neurotransmitter dopamine is released from projections originating in the midbrain. Manipulations of dopaminergic signaling profoundly influence interval timing, leading to the hypothesis that dopamine influences internal pacemaker, or "clock," activity ([@B92]; [@B15], [@B16]; [@B82]). For instance, amphetamine, which increases concentrations of dopamine at the synaptic cleft ([@B92]; [@B149]) advances the start of responding during interval timing ([@B136]), whereas antagonists of D2 type dopamine receptors typically slow timing ([@B34]; [@B82]). Animal work has indicated that manipulations of both nigrostriatal ([@B34], [@B35]; [@B95]) and mesocortical dopamine signaling originating from the ventral tegmental area ([@B105]) can also strongly influence interval timing.

In PD, midbrain projection neurons containing dopamine die ([@B31]). PD patients are slow to initiate and execute movements ([@B42]) and they also have impairments in interval timing. Early studies of PD patients off medication revealed a slowing of timing performance, which correlated with disease severity ([@B9]; [@B114]), and was consistent with bradykinesia observed with disease progression. Timing deficits were normalized by levodopa, and seem to be constrained to intervals on the scale of seconds ([@B79]). Notably, these patients had large variability in their estimates of time that was confirmed by a study in PD patients estimating two distinct intervals ([@B91]). In this study, PD patients overestimated the short interval and underestimated the long interval; when they estimated the long interval only, they were slower. This effect, dubbed the "migration effect," has been reliably found in PD patients ([@B78]). Timing deficits can be rescued by dopaminergic therapy ([@B91]), suggesting that beyond clock speed, mnemonic representation for time is impaired in PD and that dopamine influences memory as well as clock subsystems.

Parkinson's disease patients have timing impairments in related interval timing tasks. For instance, in a duration production and reproduction task with concurrent attentional loads, PD patients were more variable ([@B115]). Both levodopa and stimulation of the subthalamic nucleus improved time reproduction ([@B137]). PD patients can also have deficits in processing temporal information at sub-second time scales ([@B58]; [@B122]), but there is significant variability in timing at this scale ([@B100]; [@B72]; [@B23]). The consistency of PD timing deficits at seconds and inconsistency below milliseconds may be related to the memory and attentional load of longer time intervals ([@B79]). PD patients consistently tend to have slower, more variable timing over a scale of seconds, which implies that the loss of dopamine influences not only clock deficits in PD patients, but memory and decision processes as well ([@B98]; **Figure [1](#F1){ref-type="fig"}**).

Notably, in some studies levodopa normalizes timing ([@B91]; [@B79]) but not other executive functions such as memory, reasoning, or flexible learning ([@B56]; [@B24]; [@B113]). Dopamine signaling may be complex with non-linearities ([@B25]). Levodopa's effects may also be influenced by disease severity ([@B24]). Additionally, PD patients can be heterogeneous ([@B100]; [@B1]) with respect to the disease.

Another possibility includes a role for non-dopaminergic signaling in PD-related cognitive dysfunction. Cortical and striatal areas are influenced by other broad neurotransmitter projection systems that are also impaired in PD, such as cholinergic projections originating from basal forebrain ([@B12]). This area can be affected in PD patients ([@B7]; [@B140]; [@B51]). Furthermore, clinical trials have demonstrated that cholinesterase inhibitor improves cognitive performance for PD patients with mild--moderate dementia ([@B41]; [@B118]). Manipulations of cholinergic signaling ([@B96]) and the basal forebrain ([@B112]) can strongly influence temporal memories. It is unclear if timing deficits are also improved in these patients.

Although PD also involves degeneration of many other brainstem projection nuclei ([@B125]; [@B32]; [@B70]) such as serotonin and norepinephrine ([@B94]), the role of these systems in executive dysfunction and perceptual timing deficits is unclear. However, because levodopa does not reliably treat PD-related cognitive symptoms ([@B24], [@B26]; [@B104]; [@B113]), other non-dopaminergic mechanisms may be important for understanding cognition in PD. Future studies involving detailed correlation of neuropathology with clinical phenotypes as well as specific manipulations of non-dopaminergic systems in animal models will clarify this issue.

PD AND FRONTAL CORTEX
=====================

Deficits in interval timing have been uniformly interpreted as arising from deficits in nigrostriatal dopamine depletion affecting basal ganglia circuitry ([@B15]; [@B29]). However, we note that PD can profoundly influence the function of frontal cortex. The source of cortical dopamine projections in the medial nigral and ventral tegmental midbrain ([@B143]) degenerate in PD ([@B67]; [@B68]; [@B38]). These studies suggest that ventral tegmental dopamine neurons degenerate to a lesser extent than the nearby substantia nigra, which primarily projects to the striatum. To date, the functional consequence of ventral tegmental degeneration is unclear ([@B69]), although there is debate about the involvement of ventral tegmental area in PD ([@B43]) likely because there is much overlap between these areas.

Midbrain dopamine neurons encode errors in temporal predictions of reward ([@B60]; [@B44]; [@B77]) and can precisely encode temporal information ([@B83]). PD involves a dysfunction and loss of these neurons, which could lead to abnormalities in temporal processing in synaptic projection targets in the cortex and striatum. Without this input, these areas can be temporally desynchronized. Depletion of dopamine in healthy volunteers impairs timing ([@B30]), while amphetamine releases synaptic dopamine and speeds up timing ([@B136]). Animal models which record from both dopamine and downstream neurons or dynamically manipulate dopamine neurons while recording in downstream areas will identify the precise role that dopamine release has on temporal encoding in cortex and striatum.

Metabolic imaging demonstrates that PD patients have alterations in prefrontal dopamine signaling ([@B36], [@B37]) which has been confirmed by positron emission tomography (PET with 18F-DOPA; [@B120]; [@B74]). These studies have reported that in early PD, prefrontal dopamine uptake has been reported to be increased, presumably due to compensatory mechanisms. Dopamine influences executive function via mesocortical projections originating from the ventral tegmental area ([@B8]; [@B25]). Prefrontal dopamine release measured by microdialysis is correlated with working memory performance ([@B116]). Blocking prefrontal D1 receptors degrades the ability of prefrontal neurons to represent items in working memory ([@B142]; [@B55]; [@B139]). In rodent models, prefrontal D1 receptors are associated specifically with interval timing ([@B105]) as well as memory ([@B127]; [@B47]). In addition, prefrontal dopamine signaling has been linked with a variety of cognitive behaviors, such as reasoning ([@B135]), attentional set-shifting ([@B46]), reversal learning ([@B75]), impulsivity ([@B87]), and decision-making ([@B45]). Dopamine release in prefrontal cortex can modulate network state ([@B128]). These studies suggest that abnormalities in prefrontal dopamine signaling in PD could impair executive processing ([@B101]).

Cognitive symptoms of PD appear can be linked with dysfunction in prefrontal networks. Deactivation in medial prefrontal cortex is associated with cognitive dysfunction in PD in metabolic imaging studies ([@B61]). Brain imaging studies in PD patients have found aberrant prefrontal networks. For example, controls activated medial frontal networks more reliably than PD patients during a task of random numbers generation ([@B33]). Levodopa restored prefrontal blood flow as measured by PET during performance on a Tower-of-London task ([@B26]). Decreased performance on attentional set-shifting by PD patients is correlated with less prefrontal metabolic activity ([@B124]). This line of research suggests that there is executive dysfunction in PD that may involve the frontal cortex during timing tasks.

Several studies directly engage this question (**Table [1](#T1){ref-type="table"}**). In a study of paced-finger tapping, less medial premotor as well as sensorimotor and cerebellar activity was observed in PD patients relative to controls ([@B40]). While on and off levodopa, [@B57] asked PD patients to perform a perceptual timing task, comparing two intervals of time while collecting functional magnetic resonance images (fMRI). This study found temporal impairments throughout frontostriatal and cerebellar networks, and found abnormal activations in medial frontal and parietal areas, which are typically associated with executive processes such as working memory. Activity in this network was abnormal while PD patients encoded time and absent during the decision phase; furthermore, in medial frontal areas such as the cingulate cortex, different temporal profiles were observed in concert with temporal alterations in the striatum. A study modeling effective connectivity found that in controls, medial supplementary motor areas had excitatory coupling with subcortical areas, while PD patients did not ([@B64]). Some studies find no changes in this circuit in PD patients during timing tasks ([@B18]; [@B119]); of note, this may be related to both disease and pathological heterogeneities in PD patients ([@B100]; [@B1]). Nonetheless, PD patients with timing-related dysfunction have abnormalities in medial frontal areas (including supplementary motor areas) in addition to the basal ganglia and cerebellum.

###### 

Studies that examine the neuroanatomical basis of timing deficits and PD.

  Study     Task                              Subjects                          Hypoactive areas in PD patients
  --------- --------------------------------- --------------------------------- -------------------------------------------------------------------------------------------------------------------------
  [@B57]    Time perception task              Controls PD patients on/and off   Middle frontal cortex/parietal cortex -- temporal encoding striatal dysfunction -- time keeping
  [@B65]    Finger tapping                    Controls PD patients on/and off   No activation in medial frontal cortex, cingulate, hippocampus, accumbens during timing
  [@B40]    Finger tapping                    Controls PD patients on/and off   Decreased activation in medial premotor cortex, sensorimotor cortex, and cerebellum
  [@B18]    Internally timed movements        Controls PD patients on/and off   Similar supplementary motor and subcortical areas in PD patients OFFand controls
  [@B119]   Timed choice reaction time task   Controls vs. PD patients          Abnormal beta/alpha activity related to temporal preparation
  [@B64]    Motor timing task                 Controls vs. PD patients off      Similar area: supplementary motor, basal ganglia, cerebellum, putamen. PD patients had an inhibitory SMA-Cb connection.
  [@B63]    Motor timing                      Contols vs. PD patients off       Did not include cortical cuts; less basal ganglia/cerebellum in PD patients.

These data are supported with neurophysiological studies from animal models. For instance, in a temporal judgment task, primate prefrontal neurons predominantly encoded temporal duration ([@B53]). These same neurons were robustly modulated during the response window when a judgment was made. Similar patterns have also been observed in rodent frontal cortex ([@B106], [@B107]; [@B76]), and suggest that medial frontal cortex plays an essential role in encoding and judging temporal information.

Notably, the frontal cortex and striatum function together as a circuit ([@B5]), and several of the preceding studies involved PD-related abnormalities in the striatum as well as the frontal cortex ([@B40]; [@B57]; [@B63]) which could be modulated by dopamine ([@B65]). Effective connectivity analyses suggest that striatal and cortical areas work together to guide behavior during timing tasks ([@B64]). However, investigating the precise mechanistic relationships among areas in the frontal cortex and striatum would require recording from both areas simultaneously or inactivating one area and examining neural activity in the other. Intraoperative recording during deep-brain stimulation surgery ([@B129]) or recording from animal models ([@B106]) could investigate this question in detail.

Several investigators have suggested that timing deficits in PD may involve cognitive processing well beyond motor timing such as memory ([@B91]; [@B79]). Imaging studies have captured deficits in control processing originating from medial regions of the frontal cortex ([@B65]; [@B57]). These data suggest that interval timing and executive functions share resources in the medial frontal cortex, and that dysfunctional timing in Parkinson's patients may involve frontal as well striatal circuitry.

There are two clear implications supporting this idea. First, interval timing may be a useful clinical tool to assess the integrity of the frontostriatal system ([@B141]). One could imagine a specific interval timing paradigm to assess perceptual timing with a range of intervals spanning milliseconds to several seconds targeted at assaying both motor timing and higher order processing. As such, this task could provide early detection of timing deficits. Such a test would be simple, readily added to a neuropsychological battery or even administered remotely ([@B133]) to assist in diagnosis of disease, screen for executive dysfunction, track disease progression, and/or response to therapy.

Secondly, perceptual timing tasks can be readily trained in animals ([@B29]) such as rodents ([@B11]) or pigeons ([@B88]). This enables detailed, mechanistic investigation of neural circuits underlying the temporal organization of motivated behavior with tools such as transgenic mice ([@B35]), optogenetics ([@B105]), and neuronal ensemble recording ([@B93]; [@B76]). These circuits can be investigated in detail to understand how frontostriatal circuits are involved in perceptual timing.

In summary, we have suggested that perceptual timing is a type of executive function. Considering it as such implies that testing perceptual timing is a useful way of testing cognitive function in PD patients. Detailed mechanistic understanding of the neural circuits involved in perceptual timing in PD could lead to a greater understanding of the cognitive symptoms of PD and to targeted therapies for this difficult clinical problem.
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